The Global Market for Pain Management Drugs and Devices

Publication Date	June 2007
Publisher	BCC Research
Product Type	Report
Pages	181
ISBN Number	not applicable
Product Code	BCC00143

Price

£3,160.00
approximately: $4,848 | €3,717

PDF

PRINT £2,770 ($4,250 | €3,258)

Order above formats by FAX

Summary

The goal of BCC Research in conducting this study was to determine the present status of the worldwide pain-management market and also to evaluate its potential over the five-year period from 2007 to 2012. The pain-management market has been analyzed considering two main segments: pharmaceuticals and devices. The pharmaceuticals segment is further subdivided into different types, such as non-opioids, opioids, anticonvulsants, and antidepressants, whereas the medical devices segments is segmented into transcutaneous electrical nerve stimulation (TENS), spinal cord stimulator (SCS) and peripheral nerve stimulator (PNS), and intrathecal pumps.

Scope Of Study

This report contains:

The major types of pain-management methods, including drugs (non-opioids, opioids, anticonvulsants, and antidepressants) and devices (transcutaneous electrical nerve stimulation (TENS), spinal cord stimulator (SCS), peripheral nerve stimulator (PNS), and intrathecal pumps)
Analysis of each type of pain-relief technique, determining its current market status, its impact on future markets, and growth over the 5-year period 2007 through 2012
Technological issues, including the latest trends, plus other influential factors, such as patents, new products, and other adjuvant techniques of pain management.

Report Highlights

The global pain-management market is worth around $30.9 billion in 2007. It is forecasted to grow at a compound annual growth rate (CAGR) of 5.63% to reach $40.6 billion by the end of the forecast period, 2012.
The pharmaceuticals segment of the pain-management market is valued at $29 billion in 2007. It will be worth $38 billion by 2012 at a CAGR of 5.6%.
In 2007, market revenue from the medical devices segment is around $1.9 billion. This segment is predicted to grow at a CAGR of 6.5% to reach $2.6 billion by the end of 2012.

Content

Introduction
- Study Goals And Objectives
- Reasons For Doing This Study
- Contributions To The Study And For Whom
- Scope And Format
- Methodology
- Information Sources
- About The Author
- Related Bcc Reports
- Bcc Research Online Services
- Disclaimer
Summary
- Summary Table: Global Pain-Management Market, Through 2012 ($ Billions)
- Summary Figure: Share Of Global Pain-Management Market, By Segment 2007 And 2012 (%)
Overview
- Overview
Pain-Management Market
- What Is Pain?
- The Perception Of Pain
- Types Of Pain
  - Acute Pain
  - Chronic Pain
- Types Of Pain-Management Medications
  - Nsaid
    - Side Effects Of Nsaids
  - Opioids
    - Side Effects Of Opioids
  - Anticonvulsants
  - Antidepressants
- World Health Organization Pain Ladder
- Types Of Pain By Application
  - Burn Pain
    - Challenges Associated With Burn Pain
    - Burn Pain Management
  - Cancer Pain
    - Types Of Cancer Pain
    - Pain Management In Cancer
    - Description Of Some Of Key Medications For Cancer Pain Control
    - Morphine
    - Fentanyl
    - Hydromorphone
    - Methadone
    - Buprenorphine
    - Oxycodone
    - Diamorphine
  - Dental Pain
    - Treatment For Dental Pain
    - Acetaminophen
    - Nsaids
    - Cox-2 Inhibitors
    - Opioids
  - Pediatric Pain
    - Pediatric Pain Treatment
  - Headache Pain
    - Types Of Headache
    - Primary Headache
    - Tension Headache
    - Migraine
    - Cluster Headache
    - Secondary Headache
    - Pain Management For Headaches
    - Pain Relief Or Analgesics
    - Preventive Medication
    - Abortive Medications
  - Neuropathic Pain
  - Obstetrical Pain
    - Obstetric Pain Management
    - Regional Anesthesia
  - Surgical Pain
    - Pain Management In Surgery
  - Musculoskeletal Pain
    - Arthritis
    - Lower Back Pain
    - Musculoskeletal Pain Management
Pain-Management Market Analysis
- Methods That Provide Pain Relief
- Pain-Management Market
- Pharmaceuticals Pain Management
- Medical Devices Pain Management
Pharmaceuticals Pain-Management Market Analysis
- Global Pharmaceutical Pain-Management Market
- Market Analysis By Application
- Geographic Market Analysis
  - Geographic Distribution
- U.S. Pharmaceuticals Pain-Management Market
- European Pharmaceuticals Pain-Management Market
- Rest-Of-World Pharmaceuticals Pain-Management Market
- Competitive Structure
  - Type Of Competition
  - Tiers Of Competition
  - Mergers And Acquisitions
  - End-User Groups
  - Distribution Structure
  - Competitive Factors
  - Product Pipeline
Non-Opioid Analgesic Market
- The Nsaids Market
  - Key Challenges
    - The Fallout Due To The Vioxx And Bextra Recall
    - Relief Only For Mild To Moderate Pain
    - Side Effects Such As Gastric Ulcers And Bleeding
    - Cox Inhibitors Will Replace Traditional Nsaid Market Shares
- Product Analysis
  - The Nsaids
  - Triptans
  - Acetaminophen
- The Cox-2 Inhibitors
  - Challenges Faced By The Cox Inhibitor Market
    - The Vioxx Recal-Still Fresh In Mind
    - Only One Product Available In The U.S.
    - Uncertainty And Delay In The Launch Of New Coxs
    - High Prices Lead To Reluctance Among Physicians
  - Market Analysis Of Cox Inhibitors
- Market Analysis
  - Non-Opioid Market By Region
  - Competitive Structure
  - Market Share Analysis
The Opioids Market
- Key Challenges
  - Risk Of Addiction Discourages Physicians To Prescribe Opioids
  - Legal Risks Involved With Prescription Of Opioids
  - Risk Of Potential Patient Abuse
  - Side Effects Caused By The Use Of Opioids Discourage Patients As Well As Physicians
  - Lack Of Knowledge In Use And Prescription Of Opioids
  - Loss Of Some Key Patents Will Lead To The Entry Of Generics
- Product Analysis
  - Combination Opioids
- Market Analysis
  - Opioid Market By Region
  - Competitive Structure
  - Market Share Analysis
The Antidepressants Market
- Challenges Faced By The Antidepressants Market
  - Safety Concerns Plague The Use Of Antidepressants
  - The Increase In The Juvenile Suicide Rate Has Caused Concerns
  - The Delay By Drugs To Show Their Effects
  - Unfamiliar Treatment Guidelines
- Product Analysis
- Market Analysis
  - Market By Region
  - Competitive Structure
  - Market Share Analysis
Anticonvulsants Market
- Key Challenges
  - Very Few Approvals
  - Introduction Of Generic Compounds
- Product Analysis
- Market Analysis
  - Market By Region
  - Competitive Structure
  - Market Share Analysis
Medical Devices For Pain Management
- Key Drivers
- Types Of Devices Used In Pain Management
  - Spinal Cord Stimulator And Peripheral Nerve Stimulators
  - Transcutaneous Electrical Nerve Muscle Stimulator
  - Intrathecal Pumps And Patient Controlled Analgesia
  - Other Devices Used In Pain Management
- Market Analysis
  - Market Analysis By Type
  - Market Analysis By Region
  - Competitive Structure
    - Types Of Competition
    - Tiers Of Competition
  - Mergers And Acquisitions
    - Advanced Neuromodulation Systems And St. Jude Medical
    - Advanced Bionics Corp. And Boston Scientific
    - Empi, Inc. And Encore Medical Corp.
Adjuvant Treatment Methods For Pain Management
- Acupuncture
- Acupressure
- Biofeedback
  - Headache
    - Migraine
    - Other Headaches
  - General Pain
- Hypnosis
  - Application Of Hypnosis
- Music Therapy
- Laser Therapy
- Massage Therapy
Regulations And Key Issues In Pain Management
- Role Of Regulations In Pain Management
- Dea Schedule Of Controlled Substances
- The National Pain Care Policy Act (H.R. 1020)
  - Impact Of The National Pain Policy Of
- Barriers To Cancer Pain
  - Fear Of Addiction
  - Fear Of Side Effects
  - Inadequate Pain Assessment
  - Inadequate Knowledge/Training
  - Legal Hassles
  - Problems Related To The Healthcare System
- The Pain Consortium
  - Vioxx Recall
  - The Oxycontin Issue
Company Profiles
- Abbott Laboratories
- Astrazeneca
- Bayer Healthcare
- Biovail Corp.
- Eli Lilly And Co.
- Encore Medical
- Endo Pharmaceuticals
- Glaxosmithkline, Plc
- Javelin Pharmaceuticals
- Johnson & Johnson
- Medtronics, Inc.
- Merck & Co., Inc.
- Novartis
- Purdue Pharmaceuticals
- Roche
- Sanofi-Aventis
- St. Jude Medical
Patent Analysis
- General Trends
- Patent Analyses
  - Nsaids
  - Opioids
  - Pain-Management Medical Devices
- Trends By Company
- Conclusions
Appendix A: Key Industry Websites
- Key Regulatory And Information Websites
- Key Manufacturer Websites
Appendix B: Revenues Of Key Pharmaceutical Companies
- Currency Conversions
List Of Tables
- Summary Table: Global Pain-Management Market, Through 2012 ($ Billions)
- Table 1 Commonly Used Nsaids
- Table 2 Classes And Examples Of Opioids, Depending On Origin
- Table 3 Commonly Used Anticonvulsants In Pain Management
- Table 4 Commonly Used Antidepressants In Pain Management
- Table 5 Cancer Pain Medication
- Table 6 Pediatric Pain Management
- Table 7 Pain Management In Headaches
- Table 8 Surgical Pain Management
- Table 9 Treatment Options For Musculoskeletal Pain
- Table 10 Healthcare Demographics Of Oecd Countries
- Table 11 Global Pain-Management Market, Through 2012 ($ Billions)
- Table 12 Global Pharmaceuticals Pain-Management Market Forecast, Through 2012 ($ Billions)
- Table 13 Global Medical Devices Pain-Management Market Forecast, Through 2012 ($ Millions)
- Table 14 Global Pharmaceuticals Pain-Management Market Forecast, Through 2012 ($ Billions)
- Table 15 Global Pharmaceuticals Pain-Management Market By Type, 2007 And 2012 (%)
- Table 16 Global Pharmaceuticals Pain-Management Market Forecast By Application, Through 2012 ($ Billions)
- Table 17 Global Pharmaceuticals Pain-Management Market Shares By Application, 2007 And 2012 (%)
- Table 18 Global Pharmaceuticals Pain-Management Market By Region, Through 2012 ($ Billions)
- Table 19 Global Pharmaceuticals Pain-Management Market Shares By Region (%)
- Table 20 U.S. Pharmaceuticals Pain-Management Market, Through 2012 ($ Billions)
- Table 21 European Pharmaceuticals Pain-Management Market, Through 2012 ($ Billions)
- Table 22 Rest-Of-World Pharmaceuticals Pain-Management Market, Through 2012 ($ Billions)
- Table 23 Key Mergers And Acquisitions
- Table 24 Pain-Management Drug Product Pipelines
- Table 25 Types Of Nsaids Used In Pain Management
- Table 26 Key Challenges Of Nsaid Use
- Table 27 Otc And Prescription Nsaids
- Table 28 Nsaids And Their Uses
- Table 29 Key Triptans Available
- Table 30 Cox Inhibitors
- Table 31 Sales Of Cox-2 Inhibitors, 2002-2006 ($ Billions)
- Table 32 Global Non-Opioid Pain-Management Market, Through 2012 ($ Billions)
- Table 33 Global Non-Opioidal Pain-Management Market By Region, 2007 And 2012 (%)
- Table 34 Global Non-Opioid Pain-Management Market Shares Analysis, 2006 (%)
- Table 35 Key Challenges Faced By The Opioids Market
- Table 36 Classes Of Opioids
- Table 37 Common Opioids Available
- Table 38 Common Combination Opioids Available
- Table 39 Global Opioid Pain-Management Market, Through 2012 ($ Billions)
- Table 40 Global Opioid Pain-Management Market (%)
- Table 41 Global Opioid Pain-Management Market Share Analysis (%)
- Table 42 Key Challenges In The Antidepressants Market
- Table 43 Antidepressants Available In The U.S.
- Table 44 Global Antidepressants Pain-Management Market Forecast, Through 2012 ($ Billions)
- Table 45 Global Antidepressants Pain-Management Market Shares By Region, 2007 And 2012 (%)
- Table 46 Global Antidepressants Market Share Analysis, 2006 (%)
- Table 47 Anticonvulsants Available In The U.S.
- Table 48 Global Anticonvulsants Pain-Management Market, Through 2012 ($ Billions)
- Table 49 Global Anticonvulsants Pain-Management Market By Region, 2007 And 2012 (%)
- Table 50 Global Anticonvulsants Pain-Management Market Share Analysis, 2006 (%)
- Table 51 Key Drivers For The Pain-Management Devices Market
- Table 52 Medical Devices Pain-Management Market, Through 2012 ($ Millions)
- Table 53 Medical Devices Pain-Management Market By Segment (%)
- Table 54 Medical Devices Pain-Management Market By Region, Through 2012 ($ Millions)
- Table 55 Medical Devices Pain-Management Market Shares By Region, 2007 And 2012 (%)
- Table 56 Dea Schedule Of Controlled Substances
- Table 57 Impacts Of The Vioxx Recall
- Table 58 Impact Of Oxycontin Abuse
- Table 59 Number Of U.S. Patents Filed For The Four Major Segments,
- Table 60 Nsaid Patent Distribution, By Year, 1997-2006 (Number Of Patents)
- Table 61 Opioid Patent Distribution By Year, 1997-2006 (Number Of Patents)
- Table 62 Pain-Management Medical Device Patents By Assignee Country
- Table 63 U.S. Patents Filed By Assignee Company,
- Table 64 Revenues Of Some Key Pharmaceutical Companies, 2005 And 2006 ($ Billions)
List Of Figures
- Summary Figure: Share Of Global Pain-Management Market, By Segment 2007 And 2012 (%)
- Figure 1 Pain-Management Techniques
- Figure 2 Who Analgesic Ladder
- Figure 3 Burn Pain-Management Approach
- Figure 4 Causes Of Cancer Pain
- Figure 5 Phases In Migraines
- Figure 6 Management Of Neuropathic Pain
- Figure 7 Pain Management Methods
- Figure 8 Global Pain-Management Market,
- Figure 9 Global Pharmaceuticals Pain-Management Market Forecast, 2005-2012 ($ Billions)
- Figure 10 Global Medical Devices Pain-Management Market Forecast, 2005-2012 ($ Millions)
- Figure 11 Global Pharmaceuticals Pain-Management Market Forecast, 2005-2012 ($ Billions)
- Figure 12 Global Pharmaceuticals Pain-Management Market, 2007 (%)
- Figure 13 Global Pharmaceuticals Pain-Management Market, 2012 (%)
- Figure 14 Global Pharmaceuticals Pain-Management Market Shares By Application, 2007 (%)
- Figure 15 Global Pharmaceuticals Pain-Management Market Shares By Application, 2012 (%)
- Figure 16 Global Pharmaceuticals Pain-Management Market By Region, 2005-2012 ($ Billions)
- Figure 17 Global Pharmaceuticals Pain-Management Market Shares By Region, 2007 (%)
- Figure 18 Global Pharmaceuticals Pain-Management Market Shares By Region, 2012 (%)
- Figure 19 U.S. Pharmaceuticals Pain-Management Market, 2005-2012 ($ Billions)
- Figure 20 European Pharmaceuticals Pain-Management Market, 2005-2012 ($ Billions)
- Figure 21 Rest-Of-World Pharmaceuticals Pain-Management Market, 2005-2012 ($ Billions)
- Figure 22 Global Non-Opioid Pain-Management Market, 2005-2012 ($ Billions)
- Figure 23 Global Non-Opioidal Pain-Management Market By Region, 2007 (%)
- Figure 24 Global Non-Opioidal Pain-Management Market By Region, 2012 (%)
- Figure 25 Global Non-Opioid Pain-Management Market Shares Analysis, 2006 (%)
- Figure 26 Global Opioid Pain-Management Market, 2005-2012 ($ Billions)
- Figure 27 Global Opioid Pain-Management Market By Region, 2007 (%)
- Figure 28 Global Opioid Pain-Management Market By Region, 2012 (%)
- Figure 29 Global Opioid Pain-Management Market Shares, 2006 (%)
- Figure 30 Global Antidepressants Pain-Management Market Forecast, 2005-2012 ($ Billions)
- Figure 31 Global Antidepressants Pain-Management Market Shares By Region, 2007 (%)
- Figure 32 Global Antidepressants Pain-Management Market Shares By Region, 2012 (%)
- Figure 33 Global Antidepressants Market Share Analysis, 2006 (%)
- Figure 34 Global Anticonvulsants Pain-Management Market, 2005-2012 (% Millions)
- Figure 35 Global Anticonvulsants Pain-Management Market By Region, 2007 (%)
- Figure 36 Global Anticonvulsants Pain-Management Market By Region,
- Figure 37 Global Anticonvulsants Pain-Management Market Share Analysis, 2006 (%)
- Figure 38 Medical Devices Used In Pain Management
- Figure 39 Medical Devices Pain-Management Market, 2005-2012 ($ Millions)
- Figure 40 Medical Devices Pain-Management Market By Segment, 2007 (%)
- Figure 41 Medical Devices Pain-Management Market By Segment, 2012 (%)
- Figure 42 Medical Devices Pain-Management Market By Region, 2005-2012 ($ Millions)
- Figure 43 Medical Devices Pain-Management Market Shares, By Region, 2007 (%)
- Figure 44 Medical Devices Pain-Management Market Shares By Region, 2012 (%)
- Figure 45 Number Of U.S. Patents Filed For The Four Major Segments,
- Figure 46 Nsaid Patent Distribution By Year, 1997-2006 (Number Of Patents)
- Figure 47 Opioid Patent Distribution By Year
- Figure 48 Pain-Management Medical Device Patents By Assignee Country (Number Of Patents)
- Figure 49 U.S. Patents Filed By Assignee Company, 1997-2006 (%)